Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203837 · ClinicalTrials.gov registry record
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®
A clinical trial, sponsored by Northwestern University.
- Terminated
- Registry status
- 4
- Enrollment target
NCT03203837 is a clinical trial that was terminated before completion, run by Northwestern University. The registered enrollment target is 4 participants.
The verdict
NCT03203837 was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
To analyze specific angiogenic, inflammatory and immune profiles in hepatocellular carcinoma patients who undergo radioembolization.
Interventions
- OTHER Plasma collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2020-01-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03203837
The ClinicalTrials.gov registry entry for NCT03203837 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasma collection is the first listed.
NCT03203837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03203837 about?
NCT03203837 is a clinical study titled "Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®". To analyze specific angiogenic, inflammatory and immune profiles in hepatocellular carcinoma patients who undergo radioembolization.
What is the current status of trial NCT03203837?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2017-07-05. Estimated completion is 2020-01-06.
What interventions are being tested in trial NCT03203837?
The interventions under investigation include: Plasma collection (OTHER).
Who is sponsoring clinical trial NCT03203837?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.